ramatroban has been researched along with Arteriosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishizuka, T; Matsui, T; Ohta, A; Okamoto, Y; Shichijo, M | 1 |
1 review(s) available for ramatroban and Arteriosclerosis
Article | Year |
---|---|
Ramatroban (BAY u 3405): a novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor.
Topics: Airway Obstruction; Animals; Arteriosclerosis; Capillary Permeability; Carbazoles; Clinical Trials as Topic; Eosinophils; Humans; Nasal Mucosa; Receptors, Immunologic; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfonamides; Thromboxane-A Synthase; Tunica Intima | 2004 |